Magnetic nanoparticle stimulation to remove Alzheimer’s plaques
Magnetothermal brain stimulation towards the rescue of beta-amyloid pathology
['FUNDING_R01'] · KENT STATE UNIVERSITY · NIH-11325425
This work uses tiny magnetic particles and targeted magnetic fields to try to remove the amyloid plaques that build up in people with Alzheimer’s disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | KENT STATE UNIVERSITY (nih funded) |
| Locations | 1 site (KENT, UNITED STATES) |
| Trial ID | NIH-11325425 on ClinicalTrials.gov |
What this research studies
You would hear about a minimally invasive approach that uses superparamagnetic nanoparticles and a focused alternating magnetic field to create local heating and mechanical signals in the brain. The idea is to trigger biological processes that help clear toxic beta‑amyloid plaques and protect synapses. The research team will test this magnetothermal stimulation in lab models of Alzheimer’s disease and measure plaque clearance and effects on cognition. If preclinical results are promising, they plan steps toward translating the method for human testing.
Who could benefit from this research
Good fit: Ideal candidates would be people with Alzheimer’s disease or mild cognitive impairment linked to amyloid pathology who meet safety and eligibility criteria for a magnetothermal intervention.
Not a fit: People whose dementia is not driven by amyloid, those with very advanced Alzheimer’s, or individuals with medical conditions or implanted devices incompatible with magnetic fields may not receive benefit.
Why it matters
Potential benefit: If successful, this approach could reduce amyloid plaques and potentially slow or improve memory loss in people with Alzheimer’s disease.
How similar studies have performed: Similar magnetothermal and nanoparticle approaches have shown promise in laboratory and animal studies but remain largely experimental with little evidence yet in humans.
Where this research is happening
KENT, UNITED STATES
- KENT STATE UNIVERSITY — KENT, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KIM, MIN HO — KENT STATE UNIVERSITY
- Study coordinator: KIM, MIN HO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer disease treatment, Alzheimer syndrome